1. MelikyanG.B., Niles W.D., Peeples M.E., and Cohen F.S. 1993.
Influenza hemagglutinin-mediated fusion pores connecting cells to planar
membranes: flickering to final expansion. J. Gen. Physiol. 102:1131-1149.
2. Melikyan G.B., Niles W.D., and Cohen F.S.. 1993. Influenza virus hemagglutinin-induced cell-planar bilayer
fusion: Quantitative dissection of fusion pore kinetics into stages. J. Gen. Physiol. 102:1151-1170.
3. Melikyan G.B.,
Niles W.D., Cohen F.S. 1995. The fusion kinetics of influenza hemagglutinin
expressing cells to planar bilayer membranes is affected by HA density and host
cell surface. J. Gen. Physiol. 106:783-802.
4. Melikyan G.B., Niles W.D., Ratinov V., Karhanek M., Zimmerberg J., and Cohen F.S.. 1995.
Comparison of transient and successful fusion pores connecting influenza
hemagglutinin expressing cells to planar membranes. J. Gen. Physiol. 106:803-819.
5. Melikyan G.B., White J.M., and Cohen F.S.. 1995. GPI-anchored influenza hemagglutinin induces
hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131:679-691.
6. Melikyan G.B., Deriy B.N., Ok D.C., and Cohen F.S.. 1996. Voltage-dependent translocation of R18 and DiI across lipid
bilayers leads to fluorescence changes. Biophys. J. 71:2680-2691.
7. Melikyan G.B., Brener S.A., Ok D.C., and Cohen F.S.. 1997. Inner but not outer membrane
leaflets control the transition from glycosylphosphatidylinositol-anchored
influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 136:995-1005.
8. Melikyan G.B., Jin H., Lamb R.A., and Cohen F.S.. 1997. The role of the cytoplasmic tail region of influenza virus
hemagglutinin in formation and growth of fusion pores. Virology. 235:118-128.
9. Razinkov V.I., Melikyan
G.B., Epand R.M., Epand R.F., and Cohen F.S. 1998. Effects
of spontaneous bilayer curvature on influenza virus-mediated fusion pores. J.
Gen. Physiol. 112:409-422.
10. Melikyan G.B., Lin S., Roth M.G., and Cohen F.S.
1999. Amino acid sequence requirements of the transmembrane
and cytoplasmic domains of influenza virus hemagglutinin for viable membrane
fusion. Mol. Biol. Cell. 10:1821-1836.
11. Markosyan R.M., Melikyan G.B.,
and Cohen F.S. 1999. Tension of
membranes expressing hemagglutinin of influenza virus inhibits fusion. Biophys. J. 77:943-952.
12. Qiao H., Armstrong R.T., Melikyan G.B., Cohen
F.S., and White J.M. 1999. A specific point mutant at position 1 of the
influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell. 17:2559-2569.
13. Razinkov V.I., Melikyan G.B., and Cohen F.S. 1999. Hemifusion between cells expressing hemagglutinin of
influenza virus and planar membranes can precede the formation of fusion pores
that subsequently fully enlarge. Biophys.
J. 77:3144-3151.
14. Melikyan G.B.,
Markosyan R.M., Brener S.A., Rozenberg Y., and Cohen F.S. 2000. Role of the cytoplasmic tail of ecotropic Moloney Murine leukemia
virus Env protein in fusion pore formation. J. Virol. 74:447-455.
15. Markosyan R.M., Cohen F.S., and Melikyan
G.B. 2000. The lipid-anchored
ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing
nonenlarging fusion pores. Mol.
Biol. Cell. 11: 1143-1152.
16. Melikyan G.B., Markosyan R.M., Roth M.G., and
Cohen F.S. 2000. A point mutation
in the transmembrane domain of the hemagglutinin of influenza virus stabilizes
a hemifusion intermediate that can transit to fusion. Mol. Biol. Cell. 11:3765-3775.
17. Melikyan G.B.,
Markosyan R.M., Hemmati H., Delmedico M.K., Lambert D.M., and Cohen F.S.
2000. Evidence that the transition
of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces
membrane fusion. J. Cell Biol. 151:413-423.
18. Cohen F.S. and Melikyan
G.B. Implications of a fusion peptide structure. 2001. Nature Struct.
Biol. 8:653-655.
19. Markosyan R.M., Melikyan G.B., and Cohen F.S. 2001. Evolution of intermediates of
influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements
of pore formation. Biophys. J. 80:812-821.
20. Markosyan R.M., Ma X., Lu M., Cohen F.S., and Melikyan G.B.
2002. The mechanism of inhibition of
HIV-1 Env-mediated cell-cell fusion by recombinant gp41 ectodomain cores. Virology. 302:174-184.
21.
Markosyan R.M., Cohen F.S., and Melikyan G.B. 2003. HIV-1 envelope proteins complete their folding into six-helix
bundles immediately after fusion pore formation. Mol. Biol. Cell. 14:926-938.
22. Abrahamyan L.G., Markosyan R.M., Moore J.P., Cohen F.S., and Melikyan
G.B.. 2003. HIV-1 Env with an intersubunit disulfide bond engages
coreceptors, but requires bond reduction after engagement to induce
fusion. J. Virol. 77:5829-5836.
23. Borrego-Diaz E., Peeples M.E.,
Markosyan R.M., Melikyan G.B., and Cohen F.S.. 2003. Completion of trimeric hairpin formation of influenza virus
hemagglutinin promotes fusion pore opening and enlargement. Virology.
316:234-244.
24. Saez-Cirion A., Arrondo J.L.R., Gomara
M.J., Lorizate M., Lloro I., Melikyan G.B., and Nieva J.L.. 2003. Structural and functional roles of HIV-1 gp41
pre-transmembrane sequence segmentation. Biophys.
J. 85:3769-3780.
25. Egelhofer M., Brandenburg
G., Martinius H., Schult-Dietrich P., Melikyan G.B., Kunert R., Baum C.,
Choi I., Alexandrov A., and von Laer D.. 2003. Inhibition of HIV-1 entry in cells expressing gp41-derived
peptides. J. Virol. 78:568-575.
26. Melikyan G.B., Barnard
R.J.O., Markosyan R.M., Young J.A.T., and Cohen F.S.. 2004. Low pH is required
for ASLV Env-induced hemifusion and fusion pore formation, but not for pore
growth. J. Virol. 78:3753-3762.
27. Markosyan R.M., Bates P., Cohen F.S., and Melikyan G.B.. 2004. A study of low pH-induced
refolding of Env of Avian Sarcoma and Leukosis Virus into a six-helix bundle. Biophys. J. 87:3291-3298.
28. Abrahamyan L.G., Mkrtchyan S. R.,
Binley J., Lu M., Melikyan G.B., and Cohen F.S.. 2005. Presence of the
cytoplasmic tail slows the folding of HIV-1 Env into six-helix bundles. J. Virol. 79:106-115.
29. Melikyan
G.B., Barnard R.J.O., Abrahamyan L.G., Mothes W., and Young J.A.T. 2005.
Imaging individual retroviral fusion events: from hemifusion to pore formation
and growth. Proc. Natl. Acad. Sci. USA, 102:8728-8733.
30. Mkrtchyan
S.R., Markosyan R.M., Eadon M, Moore J.P., Melikyan G.B., and Cohen F.S.
Ternary complex formation of Human Immunodeficiency Virus type 1 Env, CD4, and
coreceptor captured as an intermediate of membrane fusion. J.
Virol., 2005, 79:11161-11169.
31. Markosyan R.M., Cohen F.S., and Melikyan G.B. Time-resolved imaging of HIV-1
Env-mediated lipid and content mixing between a single virion and cell
membrane. Mol. Biol. Cell, 2005, 16:5502-5513.
32. Melikyan
G.B., Egelhofer M., von Laer D. Membrane-anchored inhibitory peptides capture HIV-1 gp41 conformations
that engage the target membrane prior to fusion. J. Virol., 2006, 80:3249-3258.
33. Heredia, A.,
B. Gilliam, O. Latinovic, N. Le, D. Bamba, A. DeVico, G.B. Melikyan,
R.C. Gallo, R.R. Redfield. 2007. Rapamycin reduces CCR5 density levels on CD4 T
cells and this effect results in potentiation of Enfuvirtide (T-20) against R5
HIV-1 in vitro. Antimicrob. Agents Chemother. 2007, 51:2489-2496.
34. Melikyan G.B., Platt E.J., Kabat D. The role
of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the
mechanism of virus adaptation to CCR5 lacking this segment. Retrovirology, 2007, 4:55.
